LIVE
Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video
UK to offer under-40s alternative to AstraZeneca Covid-19 vaccine given rare blood clot concerns
Business
May 07, 2021
This article is being updated.
Previous article: Pfizer and BioNTech begin the process of seeking full U.S. approval for their Covid vaccine
Prev
Next article: Pfizer and BioNtech begin the process of seeking full FDA approval for their Covid vaccine
Next
via
CNBC
May 7th 2021
MixedTimes.com
Business
UK to offer under-40s alternative to AstraZeneca Covid-19 vaccine given rare blood clot concerns
Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video